Gyre Therapeutics (GYRE) Stock Chart & Stock Price History $8.09 +0.06 (+0.75%) Closing price 06/17/2025 04:00 PM EasternExtended Trading$8.07 -0.02 (-0.19%) As of 06/17/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Gyre Therapeutics Stock Price Performance The Gyre Therapeutics (GYRE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 25.09%, with a year-to-date return of -33.14%. In the past month, the stock has decreased 28.72%, reflecting recent market activity. As of the latest close, Gyre Therapeutics traded at $8.09 with a market cap of $758.50 million and volume of 86,117 shares. Receive GYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.25%1 Month Performance-28.72%3 Month Performance-5.60%Year-To-Date Performance-33.14%1 Year Performance-25.09% GYRE Stock Chart for Wednesday, June, 18, 2025 GYRE Chart by TradingView Gyre Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/17/2025$8.03$8.09+0.75%$8.42$8.0786,117 shs$758.50 million06/16/2025$7.99$8.03+0.50%$8.29$7.76165,385 shs$749.13 million06/13/2025$8.07$7.99-0.99%$8.39$7.88145,090 shs$749.13 million06/12/2025$8.44$8.07-4.38%$8.56$8.05186,739 shs$756.63 million06/11/2025$9.00$8.44-6.22%$9.19$8.44193,875 shs$791.32 million06/10/2025$8.50$9.00+5.88%$9.05$8.50247,515 shs$843.82 million06/09/2025$8.41$8.50+1.07%$8.81$8.44198,141 shs$796.94 million06/06/2025$7.97$8.41+5.52%$8.50$8.01158,311 shs$788.51 million06/05/2025$8.58$7.97-7.11%$8.77$7.92273,527 shs$747.25 million06/04/2025$8.22$8.58+4.38%$8.61$8.13194,550 shs$804.44 million Get the Latest News and Ratings for GYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/03/2025$7.68$8.22+7.03%$8.58$7.80362,572 shs$770.69 million06/02/2025$9.10$7.68-15.60%$9.28$7.58608,921 shs$720.06 million05/30/2025$9.46$9.10-3.81%$9.77$9.02231,034 shs$853.20 million05/29/2025$9.44$9.46+0.21%$9.93$9.36231,854 shs$886.95 million05/28/2025$10.18$9.44-7.27%$10.45$9.26469,726 shs$885.08 million05/27/2025$8.68$10.18+17.28%$11.61$9.801.98 million shs$954.46 million05/26/2025$8.68$8.68$10.99$8.012.11 million shs$813.82 million05/23/2025$11.21$8.68-22.57%$10.99$8.012.11 million shs$813.82 million05/22/2025$10.37$11.21+8.10%$11.31$10.21169,466 shs$1.05 billion05/21/2025$11.40$10.37-9.04%$11.50$10.23107,221 shs$972.27 million05/20/2025$11.11$11.40+2.61%$11.48$10.9054,981 shs$1.07 billion05/19/2025$11.35$11.11-2.11%$11.24$11.0050,198 shs$1.04 billion Related Companies HUTCHMED Stock Chart Crinetics Pharmaceuticals Stock Chart Catalyst Pharmaceuticals Stock Chart MorphoSys Stock Chart Metsera Stock Chart Alvotech Stock Chart Ascentage Pharma Group International Stock Chart ImmunityBio Stock Chart MoonLake Immunotherapeutics Stock Chart Organon & Co. Stock Chart Receive GYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GYRE) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GYRE Stock Free GYRE Stock Alerts